Results from the 1st-in-human clinical studies of UB-312 an alpha synuclein targeting vaccine

Results from the 1st-in-human clinical studies of UB-312 (an alpha synuclein targeting vaccine being dveloped by vaxxinity for Parkinsons & associated conditions) have been published; "Generally safe, well tolerated, & induced anti-αSyn antibodies"

movementdisorders.onlinelib...

twitter.com/ScienceofPD/sta...

[Bolt_Upright]

Thanks for sharing! I'm surprised they tested this on healthy people. I would not try it if I was healthy.

" Participants

Male and female individuals aged 40 to 85 years, with a body mass index of 18 to 32 kg/m2, who were surgically sterile or using adequate contraception, and generally healthy with no clinically relevant abnormalities based on medical history, physical examination, clinical laboratory evaluations, and 12-lead electrocardiograms (ECGs) were eligible to participate."

[Gcf51]

If Parkinson's is understood correctly, this is huge....